<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39352725</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Associations Between Acute COVID-19 Symptom Profiles and Long COVID Prevalence: Population-Based Cross-Sectional Study.</ArticleTitle><Pagination><StartPage>e55697</StartPage><MedlinePgn>e55697</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e55697</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/55697</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Growing evidence suggests that severe acute COVID-19 illness increases the risk of long COVID (also known as post-COVID-19 condition). However, few studies have examined associations between acute symptoms and long COVID onset.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aimed to examine associations between acute COVID-19 symptom profiles and long COVID prevalence using a population-based sample.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used a dual mode (phone and web-based) population-based probability survey of adults with polymerase chain reaction-confirmed SARS-CoV-2 between June 2020 and May 2022 in the Michigan Disease Surveillance System to examine (1) how acute COVID-19 symptoms cluster together using latent class analysis, (2) sociodemographic and clinical predictors of symptom clusters using multinomial logistic regression accounting for classification uncertainties, and (3) associations between symptom clusters and long COVID prevalence using modified Poisson regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In our sample (n=4169), 15.9% (n=693) had long COVID, defined as new or worsening symptoms at least 90 days post SARS-CoV-2 infection. We identified 6 acute COVID-19 symptom clusters resulting from the latent class analysis, with flu-like symptoms (24.7%) and fever (23.6%) being the most prevalent in our sample, followed by nasal congestion (16.4%), multi-symptomatic (14.5%), predominance of fatigue (10.8%), and predominance of shortness of breath (10%) clusters. Long COVID prevalence was highest in the multi-symptomatic (39.7%) and predominance of shortness of breath (22.4%) clusters, followed by the flu-like symptom (15.8%), predominance of fatigue (14.5%), fever (6.4%), and nasal congestion (5.6%) clusters. After adjustment, females (vs males) had greater odds of membership in the multi-symptomatic, flu-like symptom, and predominance of fatigue clusters, while adults who were Hispanic or another race or ethnicity (vs non-Hispanic White) had greater odds of membership in the multi-symptomatic cluster. Compared with the nasal congestion cluster, the multi-symptomatic cluster had the highest prevalence of long COVID (adjusted prevalence ratio [aPR] 6.1, 95% CI 4.3-8.7), followed by the predominance of shortness of breath (aPR 3.7, 95% CI 2.5-5.5), flu-like symptom (aPR 2.8, 95% CI 1.9-4.0), and predominance of fatigue (aPR 2.2, 95% CI 1.5-3.3) clusters.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Researchers and clinicians should consider acute COVID-19 symptom profiles when evaluating subsequent risk of long COVID, including potential mechanistic pathways in a research context, and proactively screen high-risk patients during the provision of clinical care.</AbstractText><CopyrightInformation>&#xa9; Jana L Hirschtick, Elizabeth Slocum, Yanmei Xie, Laura E Power, Michael R Elliott, Robert C Orellana, Nancy L Fleischer. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirschtick</LastName><ForeName>Jana L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-6532-1372</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advocate Aurora Research Institute, Advocate Health, 3075 Highland Parkway, Downers Grove, IL, 60515, United States, 414-219-4763.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slocum</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4373-4744</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yanmei</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6313-1660</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Power</LastName><ForeName>Laura E</ForeName><Initials>LE</Initials><Identifier Source="ORCID">0000-0002-9069-512X</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-4128-5527</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Survey Research Center, Institute for Social Research, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orellana</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0001-9655-9033</Identifier><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention Foundation, Atlanta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michigan Department of Health and Human Services, Lansing, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischer</LastName><ForeName>Nancy L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0002-4371-9133</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 CK000510</GrantID><Acronym>CK</Acronym><Agency>NCEZID CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008824" MajorTopicYN="N" Type="Geographic">Michigan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39352725</ArticleId><ArticleId IdType="pmc">PMC11460306</ArticleId><ArticleId IdType="doi">10.2196/55697</ArticleId><ArticleId IdType="pii">v10i1e55697</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID data tracker weekly review. Centers for Disease Control and Prevention.  [10-07-2023]. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html URL. Accessed.</Citation></Reference><Reference><Citation>Long COVID - household pulse survey. Centers for Disease Control and Prevention.  [17-11-2023]. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm URL. Accessed.</Citation></Reference><Reference><Citation>Long COVID basics. Centers for Disease Control and Prevention.  [24-01-2024]. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html URL. Accessed.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S, Abbafati C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022 Oct 25;328(16):1604&#x2013;1615. doi: 10.1001/jama.2022.18931. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021 Apr;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller MC, Liang CJ, Marques AR, et al. A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann Intern Med. 2022 Jul;175(7):969&#x2013;979. doi: 10.7326/M21-4905. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindahl A, Aro M, Reijula J, et al. Women report more symptoms and impaired quality of life: a survey of Finnish COVID-19 survivors. Infect Dis (Auckl) 2022 Jan 2;54(1):53&#x2013;62. doi: 10.1080/23744235.2021.1965210. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1965210</ArticleId><ArticleId IdType="pubmed">34410220</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022 Apr 9;74(7):1191&#x2013;1198. doi: 10.1093/cid/ciab611. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KGI, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021 Sep;27(9):1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021 Dec 6;73(11):e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, Titus AR, Slocum E, et al. Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis. 2021 Dec 6;73(11):2055&#x2013;2064. doi: 10.1093/cid/ciab408. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clin Nurs Res. 2022 Nov;31(8):1390&#x2013;1398. doi: 10.1177/10547738221125632. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N, Chowdhury M, Singh AK, et al. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther. 2021;15(3):156&#x2013;161. doi: 10.5582/ddt.2021.01014. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01014</ArticleId><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada-Codecido J, Chan AK, Andany N, et al. Prevalence and predictors of persistent post-COVID-19 symptoms. J Assoc Med Microbiol Infect Dis Can. 2022 Sep;7(3):208&#x2013;219. doi: 10.3138/jammi-2022-0013. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.3138/jammi-2022-0013</ArticleId><ArticleId IdType="pmc">PMC9629726</ArticleId><ArticleId IdType="pubmed">36337595</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022 Mar 31;31(163):210185. doi: 10.1183/16000617.0185-2021. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Mar;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Contact information. Michigan Department of Health and Human Services.  [10-07-2023]. https://www.michigan.gov/mdhhs/safety-injury-prev/publicsafety/ophp/contact URL. Accessed.</Citation></Reference><Reference><Citation>Standard definitions. American Association for Public Opinion Research. 2016.  [17-09-2024]. https://aapor.org/standards-and-ethics/standard-definitions/ URL. Accessed.</Citation></Reference><Reference><Citation>Coronavirus disease (COVID-19) World Health Organization.  [30-01-2024]. https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19) URL. Accessed.</Citation></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. 2022 Nov 1;79(11):1081&#x2013;1091. doi: 10.1001/jamapsychiatry.2022.2640. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox BG. The weighted sequential hot deck imputation procedure. Res Methods. 1980:721&#x2013;726.</Citation></Reference><Reference><Citation>Vermunt JK. Latent class modeling with covariates: two improved three-step approaches. Polit Anal. 2010;18(4):450&#x2013;469. doi: 10.1093/pan/mpq025. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pan/mpq025</ArticleId></ArticleIdList></Reference><Reference><Citation>Asparouhov T, Muth&#xe9;n B. Auxiliary variables in mixture modeling: three-step approaches using Mplus. Struct Equ Modeling: Multi J. 2014 Jul 3;21(3):329&#x2013;341. doi: 10.1080/10705511.2014.915181. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705511.2014.915181</ArticleId></ArticleIdList></Reference><Reference><Citation>Muth&#xe9;n L, Muth&#xe9;n B. Mplus User&#x2019;s Guide Eighth Edition. Muth&#xe9;n &amp; Muth&#xe9;n; 2017.</Citation></Reference><Reference><Citation>StataCorp . Stata Statistical Software: Release 17. StataCorp LLC; 2021.</Citation></Reference><Reference><Citation>Mariani C, Borgonovo F, Capetti AF, et al. Persistence of long-COVID symptoms in a heterogenous prospective cohort. J Infect. 2022 May;84(5):722&#x2013;746. doi: 10.1016/j.jinf.2022.01.024. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8783396</ArticleId><ArticleId IdType="pubmed">35077770</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022 Jun 10;3(6):371&#x2013;387. doi: 10.1016/j.medj.2022.04.001. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023 Oct 26;186(22):4851&#x2013;4867. doi: 10.1016/j.cell.2023.09.013. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Epsi NJ, Powers JH, Lindholm DA, et al. A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms. PLoS One. 2023;18(2):e0281272. doi: 10.1371/journal.pone.0281272. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281272</ArticleId><ArticleId IdType="pmc">PMC9910657</ArticleId><ArticleId IdType="pubmed">36757946</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023 Jun 13;329(22):1934&#x2013;1946. doi: 10.1001/jama.2023.8823. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021 Sep;114(9):428&#x2013;442. doi: 10.1177/01410768211032850. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple AC, Oddi A, Peluso MJ, et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. 2022 Feb;9(2):221&#x2013;226. doi: 10.1002/acn3.51498. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Islam M, Conroy K, et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue Biomed Health Behav. 2021;9(2):59&#x2013;68. doi: 10.1080/21641846.2021.1922140. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Madlock-Brown C, Baratta JM, et al. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumholz HM. Post-hospital syndrome--an acquired, transient condition of generalized risk. N Engl J Med. 2013 Jan 10;368(2):100&#x2013;102. doi: 10.1056/NEJMp1212324. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1212324</ArticleId><ArticleId IdType="pmc">PMC3688067</ArticleId><ArticleId IdType="pubmed">23301730</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A, Pandharipande PP, Girard TD, et al. Co-occurrence of post-intensive care syndrome problems among 406 survivors of critical illness. Crit Care Med. 2018 Sep;46(9):1393&#x2013;1401. doi: 10.1097/CCM.0000000000003218. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003218</ArticleId><ArticleId IdType="pmc">PMC6095801</ArticleId><ArticleId IdType="pubmed">29787415</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, Xie Y, Slocum E, et al. A statewide population-based approach to examining long COVID symptom prevalence and predictors in michigan. Prev Med. 2023 Dec;177:107752. doi: 10.1016/j.ypmed.2023.107752. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2023.107752</ArticleId><ArticleId IdType="pubmed">37944672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>